Enesi’s ImplaVax® enabled products have transformational potential for patients, users and suppliers, including:
- Multiple products formulated with excellent stability profiles – up to two-years’ stability demonstrated
- Enhanced immune response for vaccines demonstrated compared to standard injection
- Direct needle-free solid dose delivery – rapid administration, easy and intuitive to use for one-off and repeat-use regimens
- Strong patient preference for ImplaVax® over needle and syringe
- Single-use disposable cassettes – eliminating risk of disease transmission between individuals from shared needles
- No need to dispose of hazardous needles, syringes or vials eliminating needle stick injuries for patients and care givers, and reducing costs associated with disposal
- No need for additional diluents or water for reconstitution at point of care
- Single unitary dose – 100% dosing assured each time
- Reducing/eliminating need for cold-chain requirements
